New reports indicate that interferon γ-antisense 1 (IFNG-AS1), which is elevated in the intestinal mucosa of patients with IBD, is a mediator of the inflammatory signaling cascade in the pathophysiology of IBD [160,199]. This evidence concerns the gene IFNG-AS1 and inflammatory bowel disease.